-
Mashup Score: 47Mavacamten for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy - American College of Cardiology - 1 month(s) ago
Anthony A. Bavry, M.D., M.P.H., FACC
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 45Mavacamten for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy - American College of Cardiology - 4 month(s) ago
Anthony A. Bavry, M.D., M.P.H., FACC
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 5Prognostic Implications of the Extent of Cardiac Damage in Patients With Fabry Disease: - 6 month(s) ago
Abstract Background There is limited evidence on the risk stratification of cardiovascular outcomes in patients with Fabry disease (FD). Objectives This study sought to classify FD patients into di…
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 15Subendocardial Involvement as an Underrecognized LGE Subtype Related to Adverse Outcomes in Hypertrophic Cardiomyopathy: - 7 month(s) ago
Abstract Background Late gadolinium enhancement (LGE) has been established as an independent predictor for adverse outcomes in hypertrophic cardiomyopathy (HCM). However, the prevalence and clinica…
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet-
Location, location, location. In hypertrophic cardiomyopathy patients without extensive #whyCMR LGE, subendocardium-involved LGE rather than LGE extent was associated with adverse outcomes in multivariable models. https://t.co/9y1wbruZfz #JACCIMG #cvHCM #cvImaging #CardioTwitter https://t.co/D2ufF3zAaa
-
-
Mashup Score: 4Transcatheter Treatment of Residual Systolic-Anterior Motion and Severe Mitral Regurgitation in Hypertrophic Cardiomyopathy: - 7 month(s) ago
∗Address for correspondence: Dr Joshua Rezkalla, Department of Cardiovascular Diseases, Mayo College of Medicine, 200 First Street SW, Rochester, Minnesota 55905, USA. E-mail: E-mail Address: [email protected] Copyright © 2023, American College of Cardiology Foundation. Published by Elsevier Received April 11, 2023 Accepted May 9, 2023 Published online June 21,
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 0ACC Online Courses - American College of Cardiology - 7 month(s) ago
Find information and links to ACC Online Courses on this page.
Source: www.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Hypertrophic Cardiomyopathy: Accelerating Guideline-Driven Care - 8 month(s) ago
Hypertrophic Cardiomyopathy: Accelerating Guideline-Driven Care What You Will Learn How to distinguish HCM phenotypes Accurate cardiac imaging interpretation Monitor disease progression …
Source: learn.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Treatment| Hypertrophic Cardiomyopathy | CardioSmart – American College of Cardiology - 8 month(s) ago
Treatment for HCM may include a combination of medications, procedures, lifestyle changes, and ongoing follow-up visits and tests.
Source: www.cardiosmart.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0First-in-Human Data Show Promise for Novel Transapical Beating-Heart Septal Myectomy in HOCM - 8 month(s) ago
A new transapical beating-heart septal myectomy (TA-BSM) procedure is a safe and efficient septal reduction treatment for patients with hypertrophic obstructive cardiomyopathy (HOCM), according to new
Source: www.crtonline.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 92First-in-Human Transapical Beating-Heart Septal Myectomy in Patients With Hypertrophic Obstructive Cardiomyopathy: - 8 month(s) ago
Abstract Background To simplify surgical septal reduction therapy for hypertrophic obstructive cardiomyopathy (HOCM), we developed a novel transapical beating-heart septal myectomy (TA-BSM) procedu…
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet
The EXPLORER-HCM trial showed that mavacamten was superior to placebo at improving exercise capacity and health status. https://t.co/L3RyovnBLC #cvHCM